Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple screening program could transform cancer aftercare

NCT ID NCT05949996

Knowledge-focused Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a structured, nurse-led symptom screening program can increase the number of cancer survivors who are screened for distress and referred to supportive services. The program includes nurse training and regular feedback, and it will be rolled out across multiple clinics in a stepped fashion. The goal is to see if this systematic approach improves how often patients are screened and referred, compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A nurse-led symptom distress screening and referral program
What this could lead to
If effective, this program could become a standard way to ensure cancer survivors get the supportive care they need, improving quality of life.
What could go wrong
The trial is early and focuses on process outcomes (screening rates) rather than direct patient health benefits. Results may vary across clinics, and the program's success depends on staff adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,885 people

The number who actually took part.

Started

Jan 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All cancer patients within two years post-treatment attending the specialized outpatient clinics for surveillance will be eligible for symptom distress screening, with no exclusions by any demographic and clinical characteristics. Exclusion Criteria: * All cancer patients beyond two years post-treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neoplasms

Contacts and locations

Locations

  • JCICC

    Hong Kong, Hong Kong

  • Kwong Wah Hospital-Breast Center

    Hong Kong, Hong Kong

  • North District Hospital

    Hong Kong, Hong Kong

  • Pamela Youde Nethersole Eastern Hospital-Department of oncology

    Hong Kong, Hong Kong

  • Prince of Wales Hospital-Department of Surgery

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Obstetrics & Gynaecology

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Oncology

    Hong Kong, Hong Kong

  • Queen Mary Hospital-Department of Surgery

    Hong Kong, Hong Kong

  • The University of Hong Kong Jockey Club Institute of Cancer Care

    Hong Kong, Hong Kong

  • Tung Wah Hospital-Department of Surgery

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.